Cargando…
Stargardt disease: monitoring incidence and diagnostic trends in the Netherlands using a nationwide disease registry
PURPOSE: To assess the incidence of Stargardt disease (STGD1) and to evaluate demographics of incident cases. METHODS: For this retrospective cohort study, demographic, clinical and genetic data of patients with a clinical diagnosis of STGD1 were registered between September 2010 and January 2020 in...
Autores principales: | Runhart, Esmee H., Dhooge, Patty, Meester‐Smoor, Magda, Pas, Jeroen, Pott, Jan Willem R., van Leeuwen, Redmer, Kroes, Hester Y., Bergen, Arthur A., de Jong‐Hesse, Yvonne, Thiadens, Alberta A., van Schooneveld, Mary J., van Genderen, Maria, Boon, Camiel, Klaver, Caroline, van den Born, L. Ingeborg, Cremers, Frans P. M., Hoyng, Carel B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9291619/ https://www.ncbi.nlm.nih.gov/pubmed/34431609 http://dx.doi.org/10.1111/aos.14996 |
Ejemplares similares
-
Systemic complement activation levels in Stargardt disease
por: Dhooge, Patty P. A., et al.
Publicado: (2021) -
Correlation of Morphology and Function of Flecks Using Short-Wave Fundus Autofluorescence and Microperimetry in Patients With Stargardt Disease
por: Dhooge, Patty P. A., et al.
Publicado: (2021) -
Defining inclusion criteria and endpoints for clinical trials: a prospective cross‐sectional study in CRB1‐associated retinal dystrophies
por: Talib, Mays, et al.
Publicado: (2021) -
Commentary on “Evidence of complement dysregulation in outer retina of Stargardt disease donor eyes”
por: Dhooge, Patty P.A., et al.
Publicado: (2021) -
The STArgardt Remofuscin Treatment Trial (STARTT): design and baseline characteristics of enrolled Stargardt patients
por: Dhooge, Patty P.A., et al.
Publicado: (2022)